Reporting and Analysis Plan - ECHO Analyses From Randomized Controlled Trials of Dabrafenib to Evaluate the Potential for Cardiac Valve Abnormalities (201709)

25/08/2014
18/03/2024
EU PAS number:
EUPAS7313
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk2118346-rap-cardiacvalve-redact

English (196.56 KB - PDF) View document
Study results
Study report
Other information